Depo provera in perspective.
D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000494:pharmacology*; D004285:Dogs; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances / Q000139:chemically induced; D011247:Pregnancy; D002578:Uterine Cervical Dysplasia / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone